Dabigatran Impurity 51 | CAS 1900865-84-0 - Request Quote
Dabigatran Impurity 51
| SZ CAT No: | SZ-D012058 |
| CAS No | 1900865-84-0 |
| Mol.F. | C16H12N4O |
| Mol.Wt. | 276.3 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Dabigatran Impurity 51 is chemically N-(4-Cyanophenyl)-2-((4-cyanophenyl)amino)acetamide. Dabigatran Impurity 51 is supplied with detailed characterization data compliant with regulatory guideline. Dabigatran Impurity 51 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Dabigatran.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1900865-84-0
Purchase 1900865-84-0
Order 1900865-84-0
Enquire 1900865-84-0
price of 1900865-84-0
1900865-84-0 Supplier
1900865-84-0 Manufacturer
1900865-84-0 Exporter
buy high quality Dabigatran Impurity 51
Purchase Dabigatran Impurity 51
Dabigatran Impurity 51 suppliers
Dabigatran Impurity 51 manufacturers
Dabigatran Impurity 51 price
Order Dabigatran Impurity 51
Enquire Dabigatran Impurity 51
Dabigatran Impurity 51 cost
Dabigatran Impurity 51 Supplier
Dabigatran Impurity 51 Distributor
Dabigatran Impurity 51 for Method Validation
Dabigatran Reference Standard
Dabigatran Impurity 51 for ANDA Filing
Dabigatran Impurity 51 for Forced Degradation Studies
Dabigatran Impurity 51 Identification Standards
Dabigatran Impurity 51 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


